BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12131153)

  • 1. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy.
    Shia J; Tickoo SK; Guillem JG; Qin J; Nissan A; Hoos A; Stojadinovic A; Ruo L; Wong WD; Paty PB; Weiser MR; Minsky BD; Klimstra DS
    Am J Surg Pathol; 2002 Jul; 26(7):863-72. PubMed ID: 12131153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
    Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
    Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma].
    Jiang SM; Wang RB; Yu JM; Zhu KL; Mu DB; Xu ZF
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):602-5. PubMed ID: 19102938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.
    Kelley ST; Coppola D; Yeatman T; Marcet J
    Clin Colorectal Cancer; 2005 Jul; 5(2):114-8. PubMed ID: 16098252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.
    Wang KL; Yang Q; Cleary KR; Swisher SG; Correa AM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Oct; 107(7):1467-74. PubMed ID: 16955509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].
    Tannapfel A; Nüsslein S; Katalinic A; Köckerling F; Wittekind C; Fietkau R
    Strahlenther Onkol; 1998 Jun; 174(6):295-9. PubMed ID: 9645209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal endocrine cell micronests and single endocrine cells following neo-adjuvant therapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction.
    Stewart CJ; Hillery S
    J Clin Pathol; 2007 Nov; 60(11):1284-9. PubMed ID: 17893119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome.
    Shia J; Guillem JG; Moore HG; Tickoo SK; Qin J; Ruo L; Suriawinata A; Paty PB; Minsky BD; Weiser MR; Temple LK; Wong WD; Klimstra DS
    Am J Surg Pathol; 2004 Feb; 28(2):215-23. PubMed ID: 15043311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
    de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
    Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
    Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
    Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin-A expression in gastric and colon cancer tissues.
    Park JG; Choe GY; Helman LJ; Gazdar AF; Yang HK; Kim JP; Park SH; Kim YI
    Int J Cancer; 1992 May; 51(2):189-94. PubMed ID: 1349007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?
    Ondrejka SL; Schaeffer DF; Jakubowski MA; Owen DA; Bronner MP
    Am J Surg Pathol; 2011 Sep; 35(9):1327-30. PubMed ID: 21836482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal adenocarcinoma with oncocytic features: possible relationship with preoperative chemoradiotherapy.
    Rouzbahman M; Serra S; Chetty R
    J Clin Pathol; 2006 Oct; 59(10):1039-43. PubMed ID: 16467161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
    Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.
    Ohike N; Jürgensen A; Pipeleers-Marichal M; Klöppel G
    Virchows Arch; 2003 Mar; 442(3):258-65. PubMed ID: 12647216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer.
    Suzuki T; Sadahiro S; Fukasawa M; Ishikawa K; Kamijo A; Yasuda S; Makuuchi H; Ohizumi Y; Murayama C
    Jpn J Clin Oncol; 2004 Dec; 34(12):740-6. PubMed ID: 15640505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.